Medical Aesthetics Market: By Product (Aesthetic Lasers, Body Contouring and Skin Tightening  Devices, Aesthetic Implants, Breast Implants, Facial Implants, Other Implants), By Application (Surgical, Non-surgical), By End-user (Hospitals, Dermatology Centres, Clinics and Medical Spas, Beauty Centres, Others) and Geography

Medical Aesthetics Market size was valued at USD 10.42 billion in 2022 and is poised to grow at a significant CAGR of 11.2% from 2023-2029. Medical aesthetic devices are used for the treatment of impairments related to a person’s physical appearance, such as slackness of the skin, an excess of fat, cellulite, wrinkles, moles, scars, unwanted hair, skin discoloration, liver spots, and spider veins. Both non-surgical and surgical procedures and a combination of both are included in aesthetic medicine in order to intensify the appearance of a patient. Appropriate replacement of missing/ dysfunctional parts of the body due to congenital disorders, trauma, and accidents is also possible with aesthetic implants. Factors that are propelling the growth of the medical aesthetics market such as rise in adaptation of minimal invasive & non-invasive processes, an increase in awareness about cosmetic procedures & a rise in demand for the treatment of aesthetics among male patients, growing brand consciousness on cosmetic and beauty products increasing aging population pool, and availability of aesthetic devices which are user-friendly. However, the cost of the treatment is very high, low reimbursements and malfunctions risks concerned with implants, strict regulations on the aesthetics procedures, and the low survival rate is low because of the high potency of competitors in the market are the few factors that are hindering the growth of medical aesthetics market. The most general use of aesthetic lasers is to treat skin and hair including skin rejuvenation, tattoo removal, and eliminating pigmented lesions. Due to the non-invasive features of the medical aesthetics, they procured high preference over the other devices among patients. Facial aesthetics are anticipated to report for the major share in the medical aesthetics market due to the rising demand for facial aesthetics and growing trends of non-invasive surgeries. Energy devices are anticipated to be a speedy-growing segment of the market. Aesthetic practitioners have many choices of advanced instrumentations like flexible and soft needles, cannulas with blunt tips, and pen injectors for minimal invasive processes.

Medical Aesthetics Market Key Developments: 

• In October 2016, Merz Aesthetics received U.S. FDA approval for the Cellfina System used for the treatment of cellulite on the thighs and buttocks of females.
• In January 2016, Allergan plc received S.FDA approval for BOTOX (onabotulinumtoxinA) used to treat lower limb spasticity.
• In December 2015, Merz Aesthetics, received U.S. FDA approval for Xeomin (incobotulinumtoxinA) to treat upper limb spasticity (ULS)